CHIMERIX INC. - COMMON STOCK

Chimerix to Present at H.C. Wainwright 24th Annual Global Investment Conference

06 сен 2022 07:00:01 Источник Nasdaq GlobeNewswire

Chimerix Awarded BARDA Contract for TEMBEXA as Medical Countermeasure for Smallpox

29 авг 2022 10:45:00 Источник Nasdaq GlobeNewswire

Chimerix Reports Second Quarter 2022 Financial Results and Provides Operational Update

08 авг 2022 16:01:00 Источник Nasdaq GlobeNewswire

Chimerix Appoints Christopher L. Jordan as Vice President, Regulatory Affairs

08 авг 2022 07:00:00 Источник Nasdaq GlobeNewswire

Chimerix to Present at Wedbush PacGrow Healthcare Conference

02 авг 2022 07:00:01 Источник Nasdaq GlobeNewswire

Chimerix to Report Second Quarter 2022 Financial Results and Provide an Operational Update on August 8, 2022

01 авг 2022 16:01:00 Источник Nasdaq GlobeNewswire

Chimerix Announces TEMBEXA Procurement Agreement for Approximately $25.3 Million with Public Health Agency of Canada

24 июн 2022 10:06:16 Источник Nasdaq GlobeNewswire

Chimerix Announces $9.3 Million International TEMBEXA Procurement Agreement

23 июн 2022 09:15:16 Источник Nasdaq GlobeNewswire

Chimerix to Present at Jefferies Global Healthcare Conference

01 июн 2022 16:30:00 Источник Nasdaq GlobeNewswire

Chimerix to Present at H.C. Wainwright Global Investment Conference

17 май 2022 16:15:00 Источник Nasdaq GlobeNewswire

Chimerix Reports First Quarter 2022 Financial Results and Provides Operational Update

16 май 2022 07:00:01 Источник Nasdaq GlobeNewswire

Chimerix Announces Sale of TEMBEXA to Emergent BioSolutions for up to $337.5 Million plus Royalties

16 май 2022 06:30:00 Источник Nasdaq GlobeNewswire

Chimerix to Participate in Maxim Group Panel Discussion

12 май 2022 16:15:00 Источник Nasdaq GlobeNewswire

Chimerix to Report First Quarter 2022 Financial Results and Provide an Operational Update on May 16, 2022

09 май 2022 07:00:01 Источник Nasdaq GlobeNewswire

Chimerix to Present at Maxim Group 2022 Virtual Growth Conference

21 мар 2022 07:00:00 Источник Nasdaq GlobeNewswire

Chimerix Reports Fourth Quarter and Year End 2021 Financial Results and Provides Operational Update

01 мар 2022 07:00:02 Источник Nasdaq GlobeNewswire

Chimerix, in Collaboration with the Rapidly Emerging Antiviral Drug Development Initiative (READDI) at the University of North Carolina-Chapel Hill, Announces Late-Breaking Oral Presentation at International Conference on Antiviral Research

24 фев 2022 07:00:01 Источник Nasdaq GlobeNewswire

Chimerix to Report Fourth Quarter and Year End 2021 Financial Results and Provide an Operational Update on March 1, 2022

22 фев 2022 07:00:01 Источник Nasdaq GlobeNewswire

Chimerix to Present at B. Riley Virtual Oncology Conference

20 янв 2022 08:00:02 Источник Nasdaq GlobeNewswire

Chimerix Announces Publication of Positive ONC201 Data from Phase 2 Study in Neuroendocrine Tumors in Clinical Cancer Research

18 янв 2022 16:01:00 Источник Nasdaq GlobeNewswire